Shareholding disclosure

Kuros Biosciences AG

Collectively declared rate

3%

Threshold

Fell below threshold

Timeline

Published

10.03.2020

Transaction

05.03.2020

Voting rights breakdown

Voting rights acquired0%
Voting rights sold0%
Below threshold3%

Declared beneficial owners · 4

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders
ExchangeXSWX

Notification ID

TBK3600016

Beneficial owner

Frank-Jan van der Velden

Declared address

Frank-Jan van der Velden, Echteld

Incubation B.V., holding 1'027'101 shares (4.79% of the Company's voting rights), is controlled on a 50:50 basis by (i) Dagomar B.V., Echteld, The Netherlands, a company controlled by Mr. Frank-Jan van der Velden, Echteld, The Netherlands and (ii) Dr. C.A. van Blitterswijk Holding B.V., Ruigahuizen, the Netherlands, a company controlled by Mr. Clemens von Blitterswijk, Ruigahuizen, The Netherlands. Aldabra B.V., Amersfoort, the Netherlands, holding 1'160'106 shares (5.40% of the Company's voting rights), is controlled by Mr. Joost de Bruijn, Amersfoort, The Netherlands. Optiverder B.V., Delft, The Netherlands, holding 2'818'718 shares (13.13% of the Company's voting rights), is controlled by Mr. Chris Oomen, Delft, The Netherlands.

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open